Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or

Accuray Incorporated (ARAY) NASDAQ

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview as of [[ item.timeDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
3-Month Performance
View Chart

Fundamentals

See More
  • Market Capitalization, $K 412,550
  • Shares Outstanding, K 81,640
  • Annual Sales, $ 398,800 K
  • Annual Income, $ -25,500 K
  • 36-Month Beta 1.74
  • Price/Sales 1.03
  • Price/Book 7.72

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.55 +15.38%
on 11/10/16
5.40 -2.78%
on 11/17/16
+0.60 (+12.90%)
since 11/09/16
3-Month
4.55 +15.38%
on 11/10/16
6.39 -17.84%
on 09/30/16
-0.10 (-1.87%)
since 09/09/16
52-Week
4.55 +15.38%
on 11/10/16
7.18 -26.88%
on 12/18/15
-1.41 (-21.17%)
since 12/09/15

Most Recent Stories

More News
First Cancer Patients in the World Treated with the Smart, New Accuray Radixact(TM) System

SUNNYVALE, California, December 8, 2016 /PRNewswire/ --

First Cancer Patients in the World Treated with the Smart, New Accuray Radixact(TM) System

Accuray Incorporated (NASDAQ: ARAY) announced today that leading hospitals in Europe and the United States are now treating patients with the new Radixact(TM) Treatment Delivery System, fully integrated...

Accuray to Participate in the Citi 2016 Global Healthcare Conference

Accuray Incorporated (Nasdaq: ARAY), announced today that it will participate in the Citi 2016 Global Healthcare Conference on Thursday, December 8, 2016 in New York City. Kevin Waters, Senior Vice President...

Accuray (ARAY) Incurs Wider Loss in Q1, Misses on Revenue

Accuray Inc. (ARAY) reported a loss of 12 cents per share in the first quarter of fiscal 2017, wider than the Zacks Consensus Estimate of a loss of 10 cents.

Why Accuray (ARAY) Isn't Done Growing Earnings Yet

Accuray (ARAY) is seeing solid earnings estimate revision activity, and is a great company from a Zacks Growth perspective.

Research Reports Initiation on Medical Equipment Stocks -- Globus Medical, Align Technology, ZELTIQ Aesthetics, and Accuray

Ahead of today's trading session, Stock-Callers.com takes notice of these Medical Appliances and Equipment equities: Globus Medical Inc. (NYSE: GMED), Align Technology Inc. (NASDAQ: ALGN), ZELTIQ Aesthetics...

Accuray (ARAY) Q1 Loss Wider than Expected, Revenues Lag

Sunnyvale, CA-based Accuray Inc. (ARAY) reported a loss of 12 cents per share in the first quarter of fiscal 2017, wider than the Zacks Consensus Estimate of a loss of 10 cents.

Accuray Reports Financial Results for First Quarter and Affirms Full Year Fiscal 2017 Guidance

Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the 2017 fiscal first quarter ended September 30, 2016.

Accuray To Report Fiscal 2017 First Quarter Financial Results On October 27, 2016

Accuray Incorporated (NASDAQ: ARAY) will report results for its fiscal first quarter ended September 30, 2016 on Thursday, October 27, 2016 after the market close. Management will host a conference call...

Accuray (ARAY) Grapples with Multiple Issues: Dump Now?

On Sep 23, we issued an updated research report on Sunnyvale, CA???based Accuray Inc. (ARAY), a leading developer and designer of radiosurgery and radiation therapy systems for the treatment of tumors....

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 32% Sell with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

See More

Business Summary

ACCURAY INCORPORATED based in Sunnyvale, Calif., is a global leader in the field of radiosurgery dedicated to providing an improved quality of life and a non-surgical treatment option for those diagnosed with cancer. Accuray develops and markets the CyberKnife Robotic Radiosurgery System, which extends...

See More

Support & Resistance

2nd Resistance Point 5.35
1st Resistance Point 5.30
Last Price 5.25
1st Support Level 5.20
2nd Support Level 5.15

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.